Cargando…

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation

BACKGROUND: Gonadotropins are protein hormones which are central to the complex endocrine system that regulates normal growth, sexual development, and reproductive function. There is still a lively debate on which type of gonadotropin medication should be used, either human menopausal gonadotropin o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levi Setti, P. E., Alviggi, C., Colombo, G. L., Pisanelli, C., Ripellino, C., Longobardi, S., Canonico, P. L., De Placido, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555088/ https://www.ncbi.nlm.nih.gov/pubmed/25480425 http://dx.doi.org/10.1007/s40618-014-0204-4

Ejemplares similares

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
por: Papaleo, Enrico, et al.
Publicado: (2014)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

A Case of Suspected Isolated Follicle-Stimulating Hormone (FSH) Deficiency Where Spermatogenesis Was Acquired by Human Menopausal Gonadotropin (hMG)
por: Sugie, Miho, et al.
Publicado: (2023)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial
por: Amirzargar, Mohammad Ali, et al.
Publicado: (2012)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

SAT-295 Low Dose rFSH Prior to HCG-rFSH Therapy in Kallmann Syndrome
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2019)

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis
por: Bordewijk, E M, et al.
Publicado: (2019)

Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing
por: Bøtkjær, Jane Alrø, et al.
Publicado: (2022)

Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist
por: Chapon, Rita de Cassia Borges, et al.
Publicado: (2021)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
por: Bühler, Klaus F., et al.
Publicado: (2021)

Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols
por: Brannian, John, et al.
Publicado: (2010)

Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF
por: Gomaa, Hala, et al.
Publicado: (2012)

Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI
por: Boudjenah, Radia, et al.
Publicado: (2012)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
por: Mennini, F. S., et al.
Publicado: (2018)

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
por: Leader, Arthur, et al.
Publicado: (2013)

Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
por: Olsson, Håkan, et al.
Publicado: (2015)

Comparing clomiphen citrate plus HMG with clomiphen citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: A prospective randomized study
por: Azargoon, Azam, et al.
Publicado: (2013)

Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates.
por: Hurkadli, K. S., et al.
Publicado: (1990)

Long-acting recombinant human follicle-stimulating hormone (SAFA-FSH) enhances spermatogenesis
por: Kim, Daham, et al.
Publicado: (2023)

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
por: Yovich, John L, et al.
Publicado: (2016)

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
por: Maghraby, Hassan Ali, et al.
Publicado: (2022)

FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation
por: Abbara, Ali, et al.
Publicado: (2019)

Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation
por: Drakakis, Peter, et al.
Publicado: (2009)

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)

Abnormally Elevated Follicle-Stimulating Hormone (FSH) Level in an Infertile Woman
por: Catteau, Aurore, et al.
Publicado: (2019)

Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker—The Follicle-To-Oocyte (FOI) Index
por: Alviggi, Carlo, et al.
Publicado: (2018)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

SUN-239 A Case with Elevated Serum Follicle-Stimulating-Hormone (FSH) Concentrations Due to Macro-FSH
por: Hattori, Naoki, et al.
Publicado: (2019)

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017)

Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study
por: Barbosa, Caio Parente, et al.
Publicado: (2014)

A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)

Equine Chorionic Gonadotropin as an Effective FSH Replacement for In Vitro Ovine Follicle and Oocyte Development
por: Di Berardino, Chiara, et al.
Publicado: (2021)

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols
por: He, Bing, et al.
Publicado: (2015)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p1tt69pc8dhmoiiovh9qit194m